A global adaptive clinical trial has established which treatments will save lives in intensive care wards across Europe and Australia.

In the first year of the pandemic they tested over 30 interventions in more than 300 hospitals with  6,000 COVID patients.

“The rapid rollout of REMAP-CAP has only been possible because of years of pre-pandemic preparation backed by the European Union, Australia, New Zealand, and Canada,” says Professor Allen Cheng from Monash University and a founder of the trial. Professor Cheng is also currently serving as Victoria’s Deputy Chief Medical Officer.

Read our longer story about REMAP-CAP at https://bit.ly/3e2IRQJ

And visit them at https://www.remapcap.org/